文献
J-GLOBAL ID:201702241308736043
整理番号:17A0984179
一次選択チロシンキナーゼ阻害剤療法を受けた転移性腎細胞癌患者の生存に及ぼす最良腫瘍退縮期の影響
Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy
著者 (8件):
ISHIHARA Hiroki
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
YAGISAWA Takafumi
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
KONDO Tsunenori
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
OMAE Kenji
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
TAKAGI Toshio
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
IIZUKA Junpei
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
KOBAYASHI Hirohito
(Tokyo Women’s Medical Univ., Tokyo, JPN)
,
TANABE Kazunari
(Tokyo Women’s Medical Univ., Tokyo, JPN)
資料名:
International Journal of Clinical Oncology
(International Journal of Clinical Oncology)
巻:
22
号:
1
ページ:
126-135
発行年:
2017年02月
JST資料番号:
L3966A
ISSN:
1341-9625
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)